Connect Biopharma Holdings Limited
CNTB
$2.65
-$0.01-0.38%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | 70.44% | 70.44% |
| Total Depreciation and Amortization | -- | -- | -- | -17.50% | -31.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | 104.59% | 25.31% |
| Change in Net Operating Assets | -- | -- | -- | -293.97% | -415.69% |
| Cash from Operations | -- | -- | -- | 39.02% | 54.75% |
| Capital Expenditure | -- | -- | -- | -633.33% | 78.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -93.28% | -31.91% |
| Cash from Investing | -- | -- | -- | -94.07% | -30.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 149.79% |
| Issuance of Common Stock | -- | -- | -- | 307.78% | 181.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 472.22% | 309.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | 123.86% | 103.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -190.84% | 114.50% |